TLRY
Tilray Inc
Price:  
0.44 
USD
Volume:  
22,693,500.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TLRY EV/EBITDA

-64.7%
Upside

As of 2025-05-16, the EV/EBITDA ratio of Tilray Inc (TLRY) is 24.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TLRY's latest enterprise value is 574.54 mil USD. TLRY's TTM EBITDA according to its financial statements is 23.59 mil USD. Dividing these 2 quantities gives us the above TLRY EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 8.7x - 15.8x 11.4x
Forward P/E multiples 10.2x - 15.2x 12.6x
Fair Price 0.08 - 0.24 0.16
Upside -82.0% - -44.5% -64.7%
0.44 USD
Stock Price
0.16 USD
Fair Price

TLRY EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-14 24.42
2025-05-13 24.81
2025-05-12 25.20
2025-05-09 23.83
2025-05-08 24.46
2025-05-07 24.02
2025-05-06 23.53
2025-05-05 24.33
2025-05-02 25.01
2025-05-01 26.34
2025-04-30 26.32
2025-04-29 26.52
2025-04-28 25.96
2025-04-25 26.41
2025-04-24 26.63
2025-04-23 24.37
2025-04-22 25.14
2025-04-21 24.69
2025-04-17 24.79
2025-04-16 25.91
2025-04-15 25.78
2025-04-14 26.39
2025-04-11 26.42
2025-04-10 27.20
2025-04-09 28.28
2025-04-08 25.07
2025-04-07 30.41
2025-04-04 30.98
2025-04-03 32.09
2025-04-02 33.55
2025-04-01 33.67
2025-03-31 33.81
2025-03-28 34.04
2025-03-27 36.27
2025-03-26 33.71
2025-03-25 34.86
2025-03-24 34.89
2025-03-21 33.49
2025-03-20 33.42
2025-03-19 33.15
2025-03-18 34.61
2025-03-17 33.25
2025-03-14 31.75
2025-03-13 30.84
2025-03-12 33.04
2025-03-11 31.73
2025-03-10 33.51
2025-03-07 35.39
2025-03-06 34.61
2025-03-05 36.46